Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer Francesco Cantiello, Giorgio.

Slides:

Advertisements

Similar presentations

Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study Vincenzo Picardi, Gabriella Macchia, Alessandra Guido, Lucia Giaccherini,

Advertisements

Sperm banking is of key importance in patients with prostate cancer

Oncol Res Treat 2016;39: DOI: /

Volume 58, Issue 2, Pages (August 2010)

Volume 59, Issue 1, Pages (January 2011)

Volume 58, Issue 1, Pages (July 2010)

Volume 67, Issue 5, Pages (May 2015)

The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients

European Urology Oncology

Volume 49, Issue 2, Pages (February 2006)

Volume 61, Issue 5, Pages (May 2012)

Volume 68, Issue 3, Pages (September 2015)

Volume 51, Issue 3, Pages (March 2007)

Volume 73, Issue 3, Pages (March 2018)

European Urology Oncology

Volume 59, Issue 4, Pages (April 2011)

Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis Sebastiano Nazzani, Felix Preisser, Marco Bandini, Michele Marchioni,

Volume 71, Issue 6, Pages e171-e172 (June 2017)

Volume 72, Issue 5, Pages (November 2017)

Volume 63, Issue 4, Pages (April 2013)

Volume 63, Issue 1, Pages (January 2013)

European Urology Oncology

What is New in Bladder Cancer Diagnosis and Management?

Volume 59, Issue 6, Pages (June 2011)

Volume 68, Issue 5, Pages (November 2015)

Nomograms for Bladder Cancer

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 67, Issue 2, Pages (February 2015)

Volume 67, Issue 2, Pages (February 2015)

Volume 51, Issue 3, Pages (March 2007)

Volume 61, Issue 4, Pages (April 2012)

European Urology Oncology

Volume 48, Issue 4, Pages (October 2005)

Volume 64, Issue 3, Pages (September 2013)

European Urology Oncology

Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients Timo F.W. Soeterik,

Stephen B. Williams, Ashish M

Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,

Volume 61, Issue 5, Pages (May 2012)

Volume 66, Issue 2, Pages (August 2014)

Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non–muscle-invasive Bladder Cancer: Results of a Multicenter,

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Volume 64, Issue 1, Pages (July 2013)

Volume 53, Issue 1, Pages (January 2008)

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 71, Issue 5, Pages (May 2017)

Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA Nawar Hanna, Quoc-Dien Trinh,

Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy Matthew Mossanen, Kenneth.

Is Robot-assisted Surgery Contraindicated in the Case of Partial Nephrectomy for Complex Tumours or Relevant Comorbidities? A Comparative Analysis of.

European Urology Oncology

Kaplan-Meier curves comparing: (A) overall survival for patients treated on trial compared to those outside of a trial; (B) progression-free survival for.

European Urology Oncology

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

Cumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter Study Andrew M. Erickson, Stefano Luzzago, Axel.

European Urology Oncology

European Urology Oncology

Volume 54, Issue 1, Pages (July 2008)

Volume 52, Issue 4, Pages (October 2007)

Not All Multiparametric Magnetic Resonance Imaging–targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection.

Prognostic Factors in Non–Muscle-Invasive Bladder Tumors

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Volume 52, Issue 1, Pages (July 2007)

Oncoforum Urology: Prostate Cancer 2008 at a Glance

Volume 54, Issue 1, Pages (July 2008)

Sperm banking is of key importance in patients with prostate cancer

European Urology Oncology

Kaplan-Meier curves for PFS (panel A) and OS (panel B) of patients with mTCC receiving an anti-EGFR based therapy. mTCC, metastatic transverse colon cancer;

European Urology Oncology

How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder? Shahrokh Shariat, Paolo Gontero, James.

Presentation transcript:

Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer Francesco Cantiello, Giorgio I. Russo, Mihai Dorin Vartolomei, Abdal Rahman Abu Farhan, Daniela Terracciano, Gennaro Musi, Giuseppe Lucarelli, Savino M. Di Stasi, Rodolfo Hurle, Vincenzo Serretta, Gian Maria Busetto, Chiara Scafuro, Sisto Perdonà, Marco Borghesi, Riccardo Schiavina, Antonio Cioffi, Ettore De Berardinis, Gilberto L. Almeida, Pierluigi Bove, Estevao Lima, Giuseppe Ucciero, Deliu Victor Matei, Nicolae Crisan, Paolo Verze, Michele Battaglia, Giorgio Guazzoni, Riccardo Autorino, Giuseppe Morgia, Rocco Damiano, Ottavio de Cobelli, Vincenzo Mirone, Shahrokh F. Shariat, Matteo Ferro European Urology Oncology Volume 1, Issue 5, Pages 403-410 (October 2018) DOI: 10.1016/j.euo.2018.06.006 Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 1 Kaplan-Meier estimates of (A) recurrence-free survival and (B) progression-free survival for high-grade T1 non–muscle-invasive bladder cancer stratified by systemic inflammatory marker score. European Urology Oncology 2018 1, 403-410DOI: (10.1016/j.euo.2018.06.006) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 2 Kaplan-Meier estimates of (A) cancer-specific survival and (B) overall survival for high-grade T1 non–muscle-invasive bladder cancer stratified by systemic inflammatory marker score. European Urology Oncology 2018 1, 403-410DOI: (10.1016/j.euo.2018.06.006) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 3 Decision curve analyses demonstrating the net benefit associated with (A) the recurrence and (B) the progression probabilities model. Decision curve analysis is a method for evaluating and comparing prediction models that incorporates clinical consequences. European Urology Oncology 2018 1, 403-410DOI: (10.1016/j.euo.2018.06.006) Copyright © 2018 European Association of Urology Terms and Conditions

European Urology Oncology 2018 1, 403-410DOI: (10. 1016/j. euo. 2018 Copyright © 2018 European Association of Urology Terms and Conditions